Skip to content

Value of structural psychosocial screening in improving quality of life and satisfaction with care received in patients with lung cancer.

Value of structural psychosocial screening in improving quality of life and satisfaction with care received in patients with lung cancer.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON28655
Enrollment
250
Registered
2012-07-27
Start date
2011-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lungcancer, psychosocial signaling, Distress Thermometer and Problem list, psychosocial oncology, casemanagement, quality of life. Longkanker, psychosociale signalering, lastmeter, psychosociale oncologie, casemanagement, kwaliteit van leven.

Interventions

Patients in the standard care group will receive the usual care and attention of the health care professionals as dictated by the institute. Patients in the experimental group will receive extra psy

Sponsors

UMCG Groningen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Starting a treatment with chemotherapy for either recently confirmed diagnosis of lung cancer, documented recurrence of lung cancer, thymoma or mesothelioma; 2. Disease stage Ib - IV; 3. ECOG Performance score 0-2; 4. Age > 18 years.

Exclusion criteria

Exclusion criteria: Actual psychiatric disorder.

Design outcomes

Primary

MeasureTime frame
Quality of life (QOL) as measured by the EORTC-QLQ-30 questionnaire and its lung module QLQ-LC13, the Hospital anxiety and depression scale and the EuroQol 5 EQ-5D.

Secondary

MeasureTime frame
1. Patient satisfaction with care; 2. Total costs both inside and outside the hospital/cost effectiveness; 3. Progression free and overall survival. Measured bij Patient satisfaction questionnaire, Tic-P and generic cost-effectiveness questionnaire on top of questionaires mentioned above.

Contacts

Public ContactH.A.M. Kerstjens

P.O.Box 30.001

h.a.m.kerstjens@int.umcg.nl+31 (0)50 3612357

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)